Healthcare -
Biotechnology - NASDAQ - US
$ 8.32
2.4 %
$ 316 M
Market Cap
14.0
P/E
TRDA - OTHER LONG-TERM ASSETS
Other Long-term Assets TRDA - Entrada Therapeutics, Inc.
4.23 M
LAST VALUE
-9.85%
2 YEAR CAGR
48.76%
5 YEAR CAGR
0.00%
10 YEAR CAGR